Jason Thonhoff, MD
Enriched profileAssistant Professor of Neurology, Academic Institute, Houston Methodist · Houston Methodist
Jason Thonhoff is Assistant Professor of Neurology, Academic Institute, Houston Methodist at Houston Methodist. ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 11 Oct 2026
Overview
Updated 18 Oct 2026
Jason Thonhoff, M.D., PH.D., is Assistant Professor of Neurology, Academic Institute, Houston Methodist. The public record shows 50 publications with 2,123 citations (h-index 20), centered on ALS, Motor Neuron Disease. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 14 companies, 1 NIH-funded awards (2007–2010).
- Top research focus: ALS
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Study in ALS With Abatacept & IL-2
Sponsor: The Methodist Hospital Research Institute
- T-regulatory Cells in ALS
Sponsor: The Methodist Hospital Research Institute
Industry payments
Updated 18 Oct 2026
14 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- Biogen, Inc.Program year20248 payments
- Lilly USA, LLCProgram year20241 payment
- CATALYST PHARMACEUTICALS, INC.Program year20242 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
80.2%Other nervous system drugs30.6%Radicava Ors68%Skyclarys32%Part D<11 patientsBenzothiazole24.8%Riluzole100%Part D<11 patients+ 1 more class in this area
Musculoskeletal
19.8%Survival of Motor Neuron 2 Splicing Modifier19.8%Evrysdi100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
1 NIH research award on record, funded 2007–2010 per NIH RePORTER. The latest:
- Combined Stem Cell and Anti-Oxidative Therapy for ALS
University of Texas Med Br Galveston
FY2010$32,040F30NS060387 - Combined Stem Cell and Anti-Oxidative Therapy for ALS
University of Texas Med Br Galveston
FY2009$31,773F30NS060387 - Combined Stem Cell and Anti-Oxidative Therapy for ALS
University of Texas Med Br Galveston
FY2008$27,187F30NS060387
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Longitudinal Assessment of Biomarkers in <scp>ALS</scp> : Discriminative Biomarkers for Disease Progression and Survival
Annals of Clinical and Translational Neurology
2026 - Low-dose interleukin-2 in patients with mild to moderate Alzheimer’s disease: a randomized clinical trial
Alzheimer s Research & Therapy
2025
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →alsforums.com ↗
- M.D.
Ph.D. (physician-scientist)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →houstonmethodist.org ↗
Secondary affiliations
appointments beyond the home institution- Assistant Member
Houston Methodist Research Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houstonmethodist.org ↗ - Member
Houston Methodist Neuromuscular Clinic and Research team
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →houstonmethodist.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
William Zoghbi, MD
Houston Methodist
Eleftherios Mylonakis, MD
Houston Methodist
Dipan Shah, MD
Houston Methodist
Adi Lador, MD
Houston Methodist
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida Health